HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keith A Ching Selected Research

Keith A Ching Research Topics

Disease

8Neoplasms (Cancer)
12/2021 - 01/2012
2Stomach Neoplasms (Stomach Cancer)
02/2012 - 01/2012
1Carcinoma (Carcinomatosis)
12/2021
1Experimental Melanoma
10/2021
1Residual Neoplasm
12/2020
1Breast Neoplasms (Breast Cancer)
12/2020
1Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020
1Fatigue
01/2020
1Lymphoma (Lymphomas)
01/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2012
1Colonic Neoplasms (Colon Cancer)
03/2012
1Retinoblastoma (Glioblastoma, Retinal)
03/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2003
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
07/2003

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
12/2021 - 03/2012
2avelumabIBA
12/2021 - 11/2020
2Pharmaceutical PreparationsIBA
03/2012 - 01/2012
2Tyrosine Kinase InhibitorsIBA
02/2012 - 01/2012
1Immune Checkpoint InhibitorsIBA
12/2021
1Biological ProductsIBA
12/2021
1Interleukin-15 (Interleukin 15)IBA
10/2021
1Sunitinib (Sutent)FDA Link
11/2020
1Axitinib (AG 013736)IBA
11/2020
1LigandsIBA
11/2020
1Rituximab (Mabthera)FDA Link
01/2020
1utomilumabIBA
01/2020
1Insulin-Like PeptidesIBA
12/2013
1Insulin-Like Growth Factor Binding Protein 5IBA
12/2013
1figitumumabIBA
12/2013
1Insulin Receptor Substrate ProteinsIBA
12/2013
1N- (2- (6- (4- cyclobutylamino- 5- trifluoromethylpyrimidine- 2- ylamino)- 1,2,3,4- tetrahydro- 1,4- epiazano- naphthalen- 9- yl)- 2- oxo- ethyl)acetamideIBA
03/2012
1Aurora Kinase BIBA
03/2012
1Aurora Kinase AIBA
03/2012
1Lapatinib (GW572016)FDA Link
02/2012
1ErbB Receptors (EGF Receptor)IBA
02/2012
1Gefitinib (Iressa)FDA Link
02/2012
1Trastuzumab (Herceptin)FDA Link
02/2012
1dacomitinibIBA
02/2012
1Canertinib (CI 1033)IBA
02/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2012
1AfatinibIBA
02/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2012
12- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanolIBA
01/2012
1Proto-Oncogene Proteins c-metIBA
01/2012
1polyglutamineIBA
07/2003
1Ataxin-3IBA
07/2003
1Protein AggregatesIBA
07/2003
1UbiquitinIBA
07/2003
1Carrier Proteins (Binding Protein)IBA
07/2003

Therapy/Procedure

3Drug Therapy (Chemotherapy)
12/2021 - 02/2012
3Therapeutics
12/2021 - 02/2012
1Immunotherapy
10/2021
1Neoadjuvant Therapy
12/2020
1Precision Medicine
01/2015